As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...

Billionaire entrepreneur Mark Cuban has been vocal about reshaping the U.S. health care system for years. During recent ...

Mark Cuban Cost Plus Drug Co. has seen exponential growth since its launch, supplying thousands of healthcare facilities with discounted generics in shortage.

Roughly a year after selling much of his stake in the Mavs to Miriam Adelson and her family, Cuban has been reflecting on his ...

The Penn Medicine partnership with Mark Cuban's Cost Plus Drug Co. is designed to cut the health system's drug costs and improve access to prescription medicines. Penn Medicine has entered into a ...

The nonprofit health system’s new partnership with the Mark Cuban Cost Plus Drug Co. marketplace for businesses officially goes into effect in January. The marketplace is part of Cuban’s larger ...

The Mark Cuban Cost Plus Drug Company (MCCPDC) – a public-benefit corporation and online pharmacy that launched in 2022 with a pledge to eliminate middlemen markups on off-patent drugs and pass ...

Penn Medicine has enlisted Mark Cuban Cost Plus Drug Company to secure key generics for its retail pharmacy network. Penn will lean on the Cost Plus Marketplace for 100 of the most frequently ...

Bipartisan bills in Congress would rein them in. And businesses such as Mark Cuban’s Cost Plus Drugs and smaller, “transparent PBMs” have tried to wean pharmaceutical companies and health plans from ...

thanks to a new alliance between PharmPix and Mark Cuban Cost Plus Drug Company (Cost Plus Drugs). With over 90% of prescribed drugs in the U.S. being generics, PharmPix and Cost Plus Drugs are ...

Pharmacy benefits manager (PBM) RxPreferred has announced plans to offer the Humira biosimilar Yusimry through Mark Cuban Cost Plus Drugs – an online pharmacy launched by celebrity investor and ...

To reduce medication costs and mitigate drug shortages, Penn Medicine is uniting with Mark Cuban Cost Plus Drug Co., the health system said Dec. 6. The Philadelphia-based organization will buy the ...